Vivos Therapeutics (VVOS) Change in Cash (2020 - 2026)

Vivos Therapeutics (VVOS) has 7 years of Change in Cash data on file, last reported at $81000.0 in Q1 2026.

• On a quarterly basis, Change in Cash rose 102.07% year-over-year to $81000.0 in Q1 2026; TTM through Mar 2026 was -$232000.0, a 13.75% increase from a year earlier, with the FY2025 full-year figure at -$4.2 million, down 191.64% from the prior year.
• Change in Cash for Q1 2026 stood at $81000.0, up from -$1.1 million in the prior quarter.
• Over the last five years, Change in Cash for VVOS reached as high as $4.3 million in Q2 2024 and fell as low as -$6.2 million in Q1 2022.
• Historically, Change in Cash has averaged -$1.3 million across 5 years, with a median of -$1.1 million in 2025.
• Across the five-year window, Change in Cash soared 238.27% in 2024 and tumbled 1974.51% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$3.2 million in 2022, then soared by 120.47% to $655000.0 in 2023, then slumped by 107.79% to -$51000.0 in 2024, then tumbled by 1974.51% to -$1.1 million in 2025, then jumped by 107.66% to $81000.0 in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $81000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$1.3 million in Q3 2025.